persist
public
health
threat
infect
middl
east
respiratori
syndrom
coronaviru
merscov
highlight
need
effect
merscov
vaccin
previou
studi
focus
mainli
receptorbind
domain
rbd
spike
protein
merscov
herein
investig
immunogen
protect
potenti
recombin
ntermin
domain
rntd
spike
protein
vaccin
candid
balbc
mice
vaccin
lg
rntd
protein
demonstr
signific
humor
immun
respons
serum
igg
neutral
activ
addit
accord
enzymelink
immunospot
intracellular
cytokin
stain
cytometr
bead
array
assay
signific
function
tcell
immun
induc
lg
rntd
vaccin
aluminum
cpg
adjuv
furthermor
rntdimmun
mice
show
reduc
lung
abnorm
merscovchalleng
mous
model
transfect
adenovir
vector
express
human
show
protect
consist
found
rrbd
vaccin
data
show
rntd
induc
potent
cellular
immun
antigenspecif
neutral
antibodi
mice
demonstr
protect
capac
viral
challeng
indic
rntd
vaccin
candid
merscov
infect
middl
east
respiratori
syndrom
coronaviru
merscov
first
isol
patient
suffer
sever
respiratori
ill
saudi
arabia
phylogenet
analysi
show
viru
repres
novel
member
betacoronaviru
close
relat
bat
coronavirus
distinct
sever
acut
respiratori
syndrom
coronaviru
sarscov
sinc
merscov
continu
circul
caus
human
infect
differ
countri
includ
countri
europ
north
africa
asia
usa
middl
east
septemb
septemb
document
laboratoryconfirm
case
infect
merscov
global
includ
least
relat
death
case
fatal
rate
http
number
cluster
includ
recent
outbreak
republ
korea
indic
humantohuman
transmiss
viru
evok
global
concern
intens
discuss
worldwid
although
mani
therapeut
antibodi
includ
human
neutral
antibodi
develop
none
approv
clinic
applic
therefor
develop
effect
vaccin
merscov
infect
urgent
spike
protein
mediat
coronaviru
entri
hostcel
first
bind
receptor
hostcel
surfac
class
viral
membran
fusion
protein
ectodomain
divid
receptorbind
membranefus
subunit
contain
two
independ
domain
ntermin
domain
ntd
ctermin
domain
ctd
either
could
function
receptorbind
domain
rbd
variou
coronavirus
ntd
mous
hepat
coronaviru
mhv
recogn
carcinoembryon
antigenrel
cell
adhes
molecul
ctd
sarscov
recogn
angiotensinconvert
enzym
ntd
ctd
porcin
transmiss
gastroenter
coronaviru
tgev
recogn
sugar
aminopeptidas
n
apn
moieti
respect
merscov
util
ctd
rbd
bind
dipeptidyl
peptidas
permiss
cell
rbd
contain
major
neutral
epitop
induc
host
immun
respons
studi
focus
rbd
develop
vaccin
merscov
infect
howev
rrbd
vaccin
induc
partial
protect
merscov
challeng
mice
nonhuman
primat
nhp
addit
natur
rapid
variat
rna
viru
increas
likelihood
immunolog
escap
especi
regard
countermeasur
direct
rbd
therefor
develop
differ
immunogen
replac
use
combin
rbd
vaccin
candid
promis
strategi
merscov
infect
vaccin
merscov
infect
develop
use
purifi
coronaviru
protein
well
dna
viral
vectorbas
vaccin
express
fulllength
merscov
protein
test
abil
induc
virusneutr
antibodi
mice
recent
studi
use
serolog
analysi
develop
murin
monoclon
antibodi
show
immun
elicit
neutral
antibodi
nonrbd
portion
subunit
result
indic
protect
antigen
element
might
exist
glycoprotein
addit
rbd
studi
explor
ntd
merscov
novel
subunit
vaccin
evalu
protect
effect
merscov
infect
mous
model
anim
studi
carri
strict
complianc
guidelin
care
use
laboratori
anim
peopl
republ
china
protocol
studi
approv
committe
ethic
anim
experi
chines
center
diseas
control
prevent
procedur
perform
ethyl
ether
anesthesia
effort
made
minim
anim
suffer
shown
fig
rntd
protein
consist
signal
peptid
sp
amino
acid
aa
residu
aa
deriv
merscov
hcovemc
strain
genbank
id
code
sequenc
merscov
ntd
clone
vector
transfect
viru
amplif
conduct
cell
recombin
protein
produc
cell
purifi
use
approach
employ
rrbd
prepar
purifi
rntd
resolv
sdspage
follow
western
blot
analysi
fig
describ
previous
femal
balbc
mice
age
week
inject
intramuscularli
im
rntd
protein
dose
lg
aluminum
hydroxid
lg
cpg
adjuv
control
group
immun
aluminum
cpg
without
immunogen
day
vaccin
aluminum
mix
protein
final
concentr
mgml
thorough
mixtur
aluminum
hydroxid
protein
mix
everi
hour
shown
fig
mice
immun
three
time
interv
detect
total
igg
level
neutral
activ
mice
bled
vena
angulari
week
immun
week
last
immun
evalu
cellularmedi
immun
cmi
mice
euthan
splenocyt
isol
week
last
immun
week
last
immun
addit
vaccin
rrbd
protein
dose
lg
aluminum
lg
cpg
adjuv
appli
challeng
control
describ
previous
nine
day
last
immun
lg
rntd
rrbd
adjuv
control
mice
anesthet
lightli
isofluran
transduc
intranas
plaqueform
unit
pfu
rapid
gener
mous
model
merscov
infect
describ
previous
five
day
later
transduc
mice
infect
intranas
merscov
pfu
total
volum
dmem
three
day
postinfect
dpi
merscov
mice
euthan
lung
trachea
harvest
patholog
detect
experi
merscov
conduct
anim
biosafeti
level
facil
antigenspecif
igg
antibodi
respons
detect
elisa
describ
previous
briefli
serial
dilut
mous
sera
ad
microwel
plate
precoat
rntd
protein
ng
per
well
block
fb
wash
pbst
bound
antibodi
react
horseradish
peroxidaseconjug
antimous
igg
sigmaaldrich
st
loui
mo
us
h
sampl
wash
pbst
tetramethylbenzidin
ad
plate
reaction
stop
ad
h
absorb
read
nm
use
elisa
plate
reader
thermo
waltham
us
cutoff
valu
set
neg
control
neutral
activ
mous
sera
determin
use
merscov
pseudoviru
system
describ
previous
brief
serum
sampl
serial
dilut
twofold
tissu
cultur
plate
incub
h
addit
merscov
pseudoviru
well
mixtur
transfer
duplic
well
contain
confluent
cell
incub
h
luciferas
assay
perform
use
ultra
luminomet
tecan
hombrechtikon
ch
neutral
antibodi
effici
calcul
rel
luciferas
unit
mock
sera
rel
luciferas
unit
immun
serum
given
dilut
rel
luciferas
unit
mock
sera
prnt
assay
conduct
briefli
sera
immun
mice
serial
dilut
twofold
incub
volum
contain
merscov
hcovemc
mixtur
transfer
plate
confluent
vero
cell
h
control
viru
likewis
incub
dmem
cell
cultur
addit
h
cell
fix
paraformaldehyd
min
dy
gentian
violet
addit
min
plate
wash
tap
water
viral
plaqu
form
count
plaqu
reduct
calcul
follow
inhibit
percentag
plaqu
number
incub
seraplaqu
number
viru
titer
express
serum
dilut
result
plaqu
reduct
compar
plaqu
format
virusonli
control
evalu
antigenspecif
tcell
respons
induc
vaccin
regim
ifnc
elispot
assay
perform
describ
previous
briefli
plate
coat
per
well
mgml
antimous
ifnc
antibodi
bd
pharmingen
san
diego
ca
usa
overnight
block
h
room
temperatur
rt
freshli
harvest
splenocyt
well
stimul
triplic
h
mgml
synthes
peptid
librari
overlap
ntd
merscov
next
biotinyl
detect
antibodi
bd
pharmingen
streptavidinhorseradish
peroxidas
ad
blot
develop
addit
aec
substrat
solut
produc
color
spot
rt
incub
dark
final
ifnc
spotform
cell
sfc
count
bioread
biosi
pasadena
ca
us
ic
assay
perform
describ
previous
brief
splenocyt
sampl
cultur
h
roundbottom
microwel
plate
complet
rpmi
cultur
supplement
peptid
pool
concentr
lgml
stimul
cell
control
cell
incub
unrel
peptid
without
peptid
brefeldin
ad
incub
cell
h
stain
cell
wash
incub
min
dilut
fitclabel
antibodi
target
mous
percplabel
cell
wash
permeabil
cytofixcytoperm
min
wash
three
time
permwash
buffer
incub
buffer
min
dilut
apclabel
antibodi
target
mous
ifnc
pelabel
antibodi
target
mous
wash
cell
examin
threecolor
flow
cytometri
reagent
antibodi
purchas
bd
pharmingen
san
diego
ca
usa
investig
level
cytokin
secret
cba
analysi
conduct
describ
previous
splenocyt
well
distribut
plate
stimul
mgml
pool
peptid
includ
ntd
plate
incub
h
supernat
harvest
concentr
cytokin
includ
tnfa
ifnc
measur
use
mous
cytokin
kit
becton
dickinson
new
jersey
us
fac
calibur
flow
cytomet
becton
dickinson
franklin
lake
nj
us
data
analyz
use
fcap
array
softwar
becton
dickinson
franklin
lake
nj
us
euthan
mice
lung
trachea
collect
ihc
examin
tissu
fix
use
neutral
buffer
formalin
embed
paraffin
section
sequenti
thick
stain
prior
examin
light
microscopi
ihc
analysi
stain
method
includ
antigen
retriev
citrat
buffer
rabbitserumderiv
polyclon
antibodi
nucleoprotein
cat
sino
biolog
inc
beij
chn
incub
section
dilut
goat
antirabbit
cat
zsgbbio
beij
chn
secondari
antibodi
use
section
evalu
use
light
microscopi
variou
site
lung
trachea
tissu
sampl
collect
histopatholog
ihc
analys
final
slide
per
anim
use
quantif
assess
effect
impact
vaccin
immun
anim
statist
analys
conduct
use
oneway
anova
bonferroni
posttest
use
spss
window
softwar
packag
ver
spss
inc
chicago
il
usa
unpair
twotail
student
ttest
use
compar
mean
differ
group
valu
p
consid
indic
statist
signific
result
express
mean
standard
deviat
sd
figur
render
use
prism
softwar
packag
graphpad
softwar
san
diego
ca
usa
rntd
span
aa
merscov
protein
produc
use
bactobac
system
rntd
purifi
sdspage
coomassi
brilliant
blue
stain
shown
fig
left
rntd
recogn
polyclon
antintd
mous
serum
fig
expect
molecular
weight
kda
right
purifi
rntd
protein
evalu
dose
lg
aluminum
lg
cpg
adjuv
subunit
vaccin
candid
mice
two
week
immun
sera
immun
mice
collect
antigenspecif
igg
detect
elisa
result
show
detect
igg
sera
rntdimmun
mice
first
immun
although
antibodi
titer
low
second
immun
titer
ntd
group
peak
high
could
boost
third
immun
fig
furthermor
igg
detect
week
without
obviou
declin
three
detect
time
point
igg
titer
induc
lg
rntd
exceed
induc
lg
rntd
protein
sera
immun
mice
evalu
neutral
activ
merscov
use
pseudotyp
report
viru
neutral
assay
detect
neutral
antibodi
sera
immun
mice
week
second
immun
howev
high
titer
neutral
activ
induc
week
third
immun
w
either
lg
rntd
protein
shown
fig
moreov
neutral
activ
sera
immun
group
sustain
week
last
immun
without
obviou
declin
fig
investig
neutral
antibodi
induc
rntd
protein
prnt
assay
conduct
use
merscov
hcovemc
procedur
posit
control
consist
sera
obtain
mice
immun
dose
rrbd
protein
repres
result
shown
fig
demonstr
neutral
ntd
evid
compar
group
adjuv
although
slightli
lower
obtain
rbd
dilut
sera
ntdimmun
mice
show
signific
differ
neutral
activ
compar
rbd
protein
therefor
rntd
protein
induc
effect
neutral
antibodi
prnt
mice
titer
neutral
antibodi
lower
obtain
dose
rrbd
protein
prnt
evalu
cellular
immunolog
respons
splenocyt
immun
mice
harvest
week
last
immun
ifncsecret
cell
count
use
elispot
assay
shown
fig
dose
lg
rntd
induc
low
level
cmi
wherea
dose
lg
rntd
protein
induc
signific
cmi
level
higher
frequenc
ifncsecret
cell
addit
induc
tcell
immun
sustain
week
last
immun
without
obviou
declin
evalu
function
tlymphocyt
respons
spleen
mice
immun
lg
rntd
ic
assay
perform
week
third
immun
secret
ifnc
observ
mainli
tcell
fig
left
compar
tcell
fig
left
addit
splenocyt
rntdimmun
mice
secret
due
mainli
tcell
fig
right
compar
tcell
fig
right
cytokin
fig
fig
fig
produc
splenocyt
mice
immun
lg
rntd
analyz
cba
assay
stimul
proteinspecif
peptid
higher
concentr
induc
splenocyt
immun
mice
compar
control
group
addit
splenocyt
rntdimmun
mice
secret
higher
concentr
thu
rntd
protein
immun
induc
composit
tcell
respons
elucid
protect
effect
vaccin
histopatholog
ihc
analys
conduct
mice
challeng
merscov
shown
fig
lung
tissu
mice
control
group
exhibit
sever
lesion
includ
loss
pulmonari
alveolu
diffus
inflammatori
cell
infiltr
contrast
milder
lesion
observ
mice
immun
rntd
rrbd
pulmonari
alveolu
highli
visibl
lower
infiltr
inflammatori
cell
fig
c
similarli
compar
control
group
mice
immun
recombin
protein
show
slightli
lower
patholog
damag
trachea
fig
shown
fig
ihc
reveal
neutral
activ
sera
mice
detect
use
pseudoviru
neutral
assay
week
c
repres
result
plaqu
reduct
neutral
prnt
assay
detect
neutral
activ
sera
mice
approxim
pfu
viru
stock
hcovemc
use
infect
vero
cell
plate
without
heatinactiv
sera
immun
mice
week
third
immun
calcul
plaqu
count
statist
signific
set
p
p
threshold
statist
signific
differ
group
set
p
p
p
merscov
antigen
locat
mainli
trachea
addit
merscov
express
detect
lung
tissu
immun
group
result
indic
rntd
rrbd
vaccin
reduc
respiratori
tract
patholog
mice
challeng
merscov
howev
protect
incomplet
merscov
express
detect
immun
group
high
case
fatal
rate
vagu
defin
epidemiolog
absenc
prophylact
therapeut
measur
merscov
creat
urgent
need
effect
vaccin
studi
rntd
protein
locat
n
termin
protein
investig
potenti
prophylact
vaccin
merscov
infect
data
show
rntd
vaccin
induc
sustain
signific
titer
igg
neutral
activ
sera
immun
mice
although
titer
high
found
rrbdimmun
mice
assess
prnt
assay
addit
robust
function
tcellmedi
immun
achiev
rntdvaccin
mice
much
higher
rrbdvaccin
mice
effect
might
attribut
promin
tcell
epitop
locat
ntd
zhao
et
al
show
kyysiiphsi
locat
ntd
compris
potenti
tcell
epitop
merscov
protein
previous
verifi
protein
peptid
tikyysiiphsirsiqsd
locat
aa
residu
strongest
tcell
epitop
supplementari
fig
among
peptid
pool
overlap
protein
merscov
balbc
mice
cytokin
play
import
role
clearanc
virus
bodi
evalu
express
variou
cytokin
rntdimmun
mice
use
ic
cba
assay
ic
reveal
rntd
vaccin
elicit
high
level
tcell
ifncposit
tcell
splenocyt
cba
reveal
evid
tcell
respons
treatment
ifn
improv
outcom
merscovinfect
rhesu
macaqu
investig
whether
rntdimmun
mice
benefit
ifnc
detect
ic
cba
splenocyt
mice
immun
protect
elicit
rntd
vaccin
evalu
merscov
challeng
mous
model
transfect
adenovir
vector
express
human
control
rrbdimmun
mice
challeng
merscov
reduc
abnorm
lung
trachea
recombin
proteinimmun
mice
suggest
either
rntd
rrbd
induc
effect
protect
merscov
infect
mice
although
rntd
rrbd
protein
induc
signific
immun
mice
orient
immunolog
respons
differ
two
model
rrbd
protein
induc
higher
level
neutral
activ
prnt
assay
wherea
rntd
protein
induc
higher
cmi
level
rrbd
challeng
result
show
rrbd
rntd
protein
could
partial
protect
immun
mice
merscov
infect
immun
protect
elicit
rntd
protein
coincid
elicit
rrbd
protein
suggest
tcell
antibodi
respons
contribut
merscov
clearanc
find
support
studi
zhao
et
al
show
clearanc
merscov
mice
lack
tcell
mice
sever
combin
immunodefici
diseas
contrast
merscov
clear
b
celldefici
mice
suggest
tcell
import
acut
viru
clearanc
addit
author
show
acceler
kinet
viru
clearanc
mice
immun
sera
venezuelan
equin
enceph
replicon
particl
express
merscov
protein
prove
anti
antibodi
blockag
viru
attach
larg
suffici
merscov
clearanc
effect
final
studi
conclud
tcell
antibodi
requir
merscov
clearanc
protect
subsequ
challeng
although
rntd
protein
induc
humor
cellular
immun
respons
mice
sever
limit
interpret
data
studi
first
mechan
neutral
rntd
vaccin
mice
unknown
requir
investig
exampl
natur
neutral
antibodi
detect
pseudoviru
neutral
assay
prnt
assay
remain
unclear
second
patholog
lesion
antigen
express
indic
ihc
detect
mice
challeng
merscov
although
signific
humor
cellular
immun
elicit
rntd
vaccin
whether
result
memori
respons
need
studi
addit
limit
anim
model
restrict
assess
protect
efficaci
rntd
vaccin
mice
merscov
infect
anim
model
use
studi
develop
transduc
mice
adenoviru
vector
express
human
merscov
infect
model
highli
depend
transduct
cell
level
express
adenoviru
vector
therefor
model
may
reflect
natur
diseas
process
addit
anim
model
impos
limit
viral
titer
data
could
collect
investig
immun
system
respons
follow
clearanc
viru
rntd
vaccin
mice
anim
model
transgen
mous
might
overcom
shortcom
wherea
sever
studi
develop
transgen
mous
model
merscov
infect
nonspecif
damag
viru
detect
brain
transgen
mice
restrict
applic
model
small
anim
model
ferret
immunedefici
mice
hamster
suscept
merscov
infect
rodent
anim
model
offer
sever
advantag
evalu
vaccin
includ
avail
anim
eas
handl
low
cost
abil
use
suffici
number
statist
analysi
thu
investig
screen
vaccin
small
anim
model
first
screen
prompt
subsequ
primat
studi
sever
previou
studi
report
sar
vaccin
candid
elicit
neutral
antibodi
show
effect
protect
young
mice
hamster
challeng
howev
report
immunopatholog
reaction
older
mice
nhp
vaccin
sarscov
vaccin
subsequ
challeng
sarscov
rais
concern
vaccineassoci
diseas
enhanc
perform
clinic
trial
sarscov
vaccin
similar
concern
report
vaccineassoci
diseas
enhanc
felin
infecti
periton
viru
respiratori
syncyti
viru
vaccin
therefor
necessari
evalu
protect
rntd
protein
vaccin
nhp
model
appli
human
protect
merscov
infect
although
mani
limit
rhesu
macaqu
common
marmoset
develop
nhp
anim
model
merscov
infect
studi
show
rntd
promis
potenti
vaccin
candid
merscov
infect
knowledg
first
report
examin
target
rbd
subunit
vaccin
merscov
infect
find
contribut
understand
function
ntd
protein
merscov
develop
prevent
therapeut
strategi
merscov
infect
studi
also
contribut
develop
suitabl
anim
model
evalu
protect
effici
rntd
protein
vaccin
investig
effect
target
antigen
protect
merscov
infect
